Holger A Liepmann - Executive Vice President, Abbott Laboratories

As of December 30, 2010


Holger A Liepmann Net Worth

  • Net worth is estimated to be at least $15.65M
  • Owns at least 169,571 units of Abbott Laboratories stock
  • Sold an estimated value of $20.23M in the last 6 years at Abbott Laboratories

Holger A Liepmann Trading

  • Largest purchase of shares was 48,600 units , worth over $2.55M on February 20, 2007
  • Largest sale of shares was 30,000 units , worth over $1.73M on July 24, 2008
  • In total has made about 35 transactions over 6 years
  • Usually trades in February, with the busiest year in 2009
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Abbott Laboratories Executive Compensation

Name
Year
Other Earnings Plans or Compensations
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Change in Pension Value
Other Compensation
Other Earnings Plans or Compensations
Change in Pension Value
Robert B. Ford, 2020 $20,450,586 $1,298,462 $5,623,995 $5,624,993 $20,450,586 $16,549,550 $77,872 $20,450,586 $16,549,550
Robert B. Ford, 2019 $11,897,886 $1,000,000 $3,475,992 $3,476,054 $11,897,886 $9,777,514 $71,841 $11,897,886 $9,777,514
Robert B. Ford, 2018 $8,127,252 $784,250 $2,691,621 $2,691,897 $8,127,252 $7,821,493 $279,213 $8,127,252 $7,821,493
Robert E. Funck, Jr., 2020 $ $ $ $ $ $ $ $ $
Hubert L. Allen, 2020 $8,478,177 $751,346 $1,874,607 $1,874,988 $8,478,177 $5,919,894 $154,596 $8,478,177 $5,919,894
Hubert L. Allen, 2019 $7,486,080 $710,000 $2,199,962 $2,199,990 $7,486,080 $6,386,933 $66,905 $7,486,080 $6,386,933
Hubert L. Allen, 2018 $7,317,776 $706,709 $2,691,621 $2,691,897 $7,317,776 $7,278,480 $120,316 $7,317,776 $7,278,480
John F. Ginascol, 2020 $ $ $ $ $ $ $ $ $
Daniel G. Salvadori, 2020 $5,975,739 $710,000 $1,901,708 $1,902,099 $5,975,739 $5,518,569 $79,421 $5,975,739 $5,518,569
Daniel G. Salvadori, 2019 $6,767,814 $704,923 $2,351,989 $2,351,986 $6,767,814 $6,388,821 $59,806 $6,767,814 $6,388,821
Daniel G. Salvadori, 2018 $5,954,210 $675,038 $1,993,798 $1,993,992 $5,954,210 $5,907,979 $434,514 $5,954,210 $5,907,979
Miles D. White, 2020 $ $ $ $ $ $ $ $ $
Miles D. White, 2019 $ $ $ $ $ $ $ $ $
Miles D. White, 2018 $ $ $ $ $ $ $ $ $
Brian B. Yoor, 2020 $3,489,479 $207,837 $1,231,027 $1,231,237 $3,489,479 $2,839,222 $38,264 $3,489,479 $2,839,222
Brian B. Yoor, 2019 $9,015,698 $825,000 $2,449,976 $2,449,987 $9,015,698 $7,031,097 $71,331 $9,015,698 $7,031,097
Brian B. Yoor, 2018 $7,612,836 $796,057 $2,691,621 $2,691,897 $7,612,836 $7,280,548 $73,483 $7,612,836 $7,280,548
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1800/000104746921000592/a2242988zdef14a.htm

Abbott Laboratories Insider Trading

  • The most recent transaction was 16,000 units sold on December 28, 2021 by Andrea F Wainer worth over $2.25M
  • In the last 18 years, insiders at Abbott Laboratories sold an estimated value of $1.71B and bought an estimated value of $1.14B
  • The most active traders are Miles D White, EXECUTIVE CHAIRMAN,  Stephen R Fussell, Executive Vice President,  and Robert J Alpern
  • Insider trading is most common in February, with the busiest year in 2009

ABBOTT LABORATORIES Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1